Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and Studies AUSTIN, Texas, Jan. 7, 2026 /PRNewswire/ -- Genprex, Inc.
Company Achieves Clinical Development Milestones in 2025, Advances Program for Future Scale Up and StudiesAUSTIN, Texas, Jan.
Hello, this is Chris York reporting from Kyiv on day 1,413 of Russia's full-scale invasion of Ukraine. Today's top story: A Russian Shahed-type drone reportedly downed in Chernihiv Oblast was armed ...
Enrollment in 4D-150 Phase 3 wet AMD clinical trials exceeding expectations; 4FRONT-1 trial remains on track to complete enrollment in Q1 2026, with 381 patients randomized or approved to randomize as ...
The Vacaville Reporter on MSN

Vacaville Council hears downtown updates

Vacaville’s downtown makeover, years in the making and tens of millions of dollars deep, came into sharper focus Tuesday ...